The pathogenesis of pemphigus: Controversy vs complexity

Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology

(2016) A. Razzaque Ahmed et al.   EXPERIMENTAL DERMATOLOGY

The mitochondrion is a common target of disease pathophysiology in pemphigus and pemphigoid

(2015) Sergei A. Grando   EXPERIMENTAL DERMATOLOGY

Immune response in pemphigus and beyond: progresses and emerging concepts

(2015) Giovanni Di Zenzo et al.   Seminars in Immunopathology

Preclinical Studies Identify Non-Apoptotic Low-Level Caspase-3 as Therapeutic Target in Pemphigus Vulgaris

(2015) Camille Luyet et al.   PLoS One

EGFR inhibitors erlotinib and lapatinib ameliorate epidermal blistering in pemphigus vulgaris in a non-linear, V-shaped relationship

(2013) Beyza S. Sayar et al.   EXPERIMENTAL DERMATOLOGY

An Adult Passive Transfer Mouse Model to Study Desmoglein 3 Signaling in Pemphigus Vulgaris

(2011) Katja Schulze et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Autoimmunity to Desmocollin 3 in Pemphigus Vulgaris

(2010) Xuming Mao et al.   AMERICAN JOURNAL OF PATHOLOGY

Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients

(2010) Enno Schmidt et al.   EXPERIMENTAL DERMATOLOGY